Sickle Cell Disease (SCD) and Nephropathy research hub

A Phase 2, Open-label, Multicenter Study of Mitapivat in Subjects With Sickle Cell Disease and Nephropathy

This study is testing a new medicine called Mitapivat for people with Sickle Cell Disease and kidney problems. Researchers want to see if it can help reduce kidney damage and improve health, checking for how safe and effective it is over six months.